Filings accepted for afatinib as second-line treatment for squamous cell carcinoma of the lung Aug. 25, 2015
EMA to review MAA for palbociclib plus endocrine therapy for HR+/HER2- metastatic breast cancer Aug. 21, 2015
RSS